Compare MIST & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MIST | CRT |
|---|---|---|
| Founded | 2003 | 1991 |
| Country | Canada | United States |
| Employees | N/A | 2 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.2M | 54.1M |
| IPO Year | 2019 | N/A |
| Metric | MIST | CRT |
|---|---|---|
| Price | $1.26 | $9.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 14.9K |
| Earning Date | 05-13-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 5.29% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $7.07 |
| 52 Week High | $3.06 | $11.10 |
| Indicator | MIST | CRT |
|---|---|---|
| Relative Strength Index (RSI) | 55.92 | 49.64 |
| Support Level | $1.20 | $9.29 |
| Resistance Level | $1.42 | $10.25 |
| Average True Range (ATR) | 0.07 | 0.24 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 91.07 | 43.46 |
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.